Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM & Directorate Change

11 May 2022 14:01

RNS Number : 1445L
Maven Income & Growth VCT 4 PLC
11 May 2022
 

Maven Income and Growth VCT 4 PLC (the Company) - Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 12 noon at the offices of Maven Capital Partners UK LLP, 1-2 Royal Exchange Buildings, London EC3V 3LF on Wednesday 11 May 2022, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 9 May 2022, the total number of voting rights in the Company stood at 128,766,420 Ordinary Shares. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 8,613,156 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

8,267,596

325,098

12,757

7,705

8,613,156

2

To approve the Directors' Remuneration Report.

7,901,337

360,064

211,747

140,008

8,613,156

3

To approve the final dividend.

 

8,275,562

315,396

4,461

17,737

8,613,156

4

To re-elect Mr Linthwaite as a Director.

 

8,098,363

355,800

47,862

111,131

8,613,156

5

To re-elect Mr Scott as a Director.

 

8,077,000

335,774

136,747

63,635

8,613,156

6

To re-elect Mr Nixon as a Director.

 

7,899,420

581,848

80,581

51,307

8,613,156

7

To re-elect Mr Gray as a Director.

 

8,171,572

358,087

31,359

52,138

8,613,156

8

To re-appoint Deloitte LLP as Auditor.

 

7,236,184

332,556

1,003,179

41,237

8,613,156

9

To authorise the Directors to fix the remuneration of the Auditor.

8,182,288

335,224

49,121

46,523

8,613,156

10

To authorise the Directors to allot new shares.

7,279,399

332,556

911,713

89,488

8,613,156

11

To authorise disapplication of pre-emption rights.

7,014,748

336,462

1,173,139

88,807

8,613,156

12

To authorise the Company to purchase its own shares.

6,843,861

331,101

1,389,916

48,278

8,613,156

13

To allow a General Meeting to be called on not less than 14 days' notice.

7,837,153

331,101

396,735

48,167

8,613,156

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

Directorate Change

As highlighted in the Annual Report for the year ended 31 December 2021, Malcolm Graham-Wood retired from the Board with effect from the conclusion of the AGM. The Board expresses its sincere gratitude to Malcolm for his considerable contribution to the success of the Company during his time in office and wishes him every success for the future.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

11 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGZGMKFMGGZZM
Date   Source Headline
1st May 202410:08 amRNSIssue of Equity
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.